Publications
Single-cell phenotyping to unravel the immunopathology of immune checkpoint inhibitor-related pneumonitis. Lessons learnt from the COVID-19 pandemic KU Leuven
Effect of pembrolizumab on biomarkers related to intratumoral immunity, proliferation and apoptosis in early breast cancer KU Leuven
TIM3 Checkpoint Inhibition Fails to Prolong Survival in OvarianCancer-Bearing Mice Vrije Universiteit Brussel
A decrease in peripheral thyroid hormone conversion efficiency in patients treated with immune checkpoint inhibitors and L-T3 as a possible alternative therapeutic escape option KU Leuven University of Antwerp
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade KU Leuven
Safe Use of Immune Checkpoint Inhibitors in the Multidisciplinary Management of Urological Cancer: The European Association of Urology Position in 2019 KU Leuven
Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab Vrije Universiteit Brussel
It is well known that organ transplant recipients are prone to develop non-melanoma skin cancers, particularly cutaneous squamous cell carcinoma (cSCC). This is explained by the long-term use of immunosuppressants and thus the decrease of the immunosurveillance that protects from developing malignant tumours. Solid organ transplant recipients (SOTRs) are 65-250 times more likely to develop cSCC compared to the general population (Am J ...
The predictive and prognostic value of weight loss and body composition prior to and during immune checkpoint inhibition in recurrent or metastatic head and neck cancer patients KU Leuven
Severe treatment-induced inflammatory polyarthritis in advanced melanoma patients Vrije Universiteit Brussel
Immune checkpoint inhibitors (ICI) and targeted therapies form the therapeutic mainstay for v-Raf murine sarcoma viral oncogene homolog B V600-mutated metastatic melanoma. Both treatment regimens can cause inflammatory arthritis. The reported incidence of treatment-induced inflammatory arthritis is low, though presumably underestimated due to lack of awareness, clear definitions and uniform grading systems. Nevertheless, recognition is ...